CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign

Go back to CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
(AMEX: CSLLY) Delayed: 32.41 +0.20 (0.62%)
Previous Close $32.21    52 Week High $45.60 
Open $32.07    52 Week Low $33.39 
Day High $32.41    P/E N/A 
Day Low $32.07    EPS $0.00 
Volume 1,812